Szpital św. Anny w Miechowie
- Address
- lock Available on a paid plan
Szpital św. Anny w Miechowie - Cardiovascular Research Center
Szpital św. Anny w Miechowie is a specialized medical research center focused on advanced cardiovascular disease research. The center participates in cutting-edge international clinical trials investigating novel therapeutic approaches for patients with atherosclerotic cardiovascular disease (ASCVD), particularly those whose existing lipid-modifying treatments have not achieved adequate disease control.
- Atherosclerotic cardiovascular disease and plaque buildup management
- Advanced lipid-modifying therapies and cholesterol management
- Prevention of major adverse cardiovascular events (MACE)
The facility's research portfolio emphasizes Phase 3 clinical trials evaluating innovative pharmacological interventions aimed at reducing the risk of major adverse cardiovascular events, including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and non-elective coronary revascularization. This research contributes to advancing treatment options for patients with complex cardiovascular conditions who require enhanced therapeutic strategies beyond standard care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Cytokinetics Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Szpital św. Anny w Miechowie
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Omecamtiv Mecarbil in Patients with Heart Failure and Severely Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial | Cytokinetics Inc. | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Evolocumab | 1 | Unknown | 2019-05-24 | 2019-05-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.